Recognition and management of bacterial arthritis

Drugs

Volumn 54, Issue 1, 1997, Pages 50-60

  Cimmino, Marco A ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL DNA; BACTERIAL TOXIN; CAPREOMYCIN; CEFTRIAXONE; CEPHALOSPORIN; CORTICOSTEROID; CYTOKINE; DOXYCYCLINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LYMPHOCYTE SURFACE MARKER; MEZLOCILLIN; MONOCLONAL ANTIBODY; OFLOXACIN; PENICILLIN G; PIPERACILLIN; PYRAZINAMIDE; RIFAMPICIN; SPECTINOMYCIN; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

AUTOIMMUNITY; BACTERIAL ARTHRITIS; BACTERIUM CULTURE; BORRELIA BURGDORFERI; BRUCELLOSIS; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; INFECTIOUS ARTHRITIS; INTRAARTICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYME DISEASE; MYCOBACTERIUM; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SCINTIGRAPHY; SURGICAL DRAINAGE; SYNOVIAL FLUID; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); BORRELIA; BORRELIA BURGDORFERI; MYCOBACTERIUM; POSIBACTERIA;

EID: 0030841085     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199754010-00004     Document Type: Review

References (68)

1. Goldenberg DL. Bacterial arthritis. In: Kelley WN, Harris ED, Ruddy S, et al., editors. Textbook of rheumatology. Philadelphia: Saunders, 1993: 1449-66
2. Meyer JL, Hoffman GS. Mycobacterial and fungal infections. In: Kelley WN, Harris ED, Ruddy S, et al., editors. Textbook of rheumatology. Philadelphia: Saunders, 1993: 1467-83
3. Schnitzer TJ. Viral arthritis. In: Kelley WN, Harris ED, Ruddy S, et al., editors. Textbook of rheumatology. Philadelphia: Saunders, 1993: 1494-508
4. Huppertz H, Niki NPH, Chantler JK. Susceptibility of normal human joint tissue to viruses. J Rheumatol 1991; 18: 699-704
5. Cimmino MA, Picciotto A, Sinelli N, et al. Has hepatitis C virus a specific tropism for the synovial membrane? Br J Rheumatol. In press
6. Feng L, Bulbul R, Schumacher RH, et al. Molecular detection of bacterial DNA in venereal-associated arthritis, Arthritis Rheum 1996; 19: 950-8
7. Granfors K, Julkanen S, von Essen R, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320: 216-21
8. Snydman DR, Schenken DP, Berardi VP, et al. Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. Ann Intern Med 1986; 104: 798-800
9. Weyand CM, Goronzy JJ. Immune responses to Borrelia burgdorferi in patients with reactive arthritis. Arthritis Rheum 1989; 32: 1057-64
10. Scofield RH, Warren WL, Koelsch G, et al. A hypothesis for the immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides hound by B27 and convergent evolution. Proc Natl Acad Sci USA 1993; 90: 9330-4
11. Ho Jr G. Bacterial arthritis. Curr Opin Rheumatol 1992; 4: 509-15
12. Goldenberg DL. Bacterial arthritis. Curr Opin Rheumatol 1994; 6: 394-400
13. Goldenberg DL. Bacterial arthritis. Curr Opin Rheumatol 1995; 7: 310-4
14. Hedström SA. Septic hone and joint infections. Curr Opin Rheumatol 1996; 8: 322-6
15. Patti JM, Bremell T, Krajewska-Pietrasik D, et al. The Staphvlococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 1994; 62: 152-61
16. Saez-Llorens X, Mustafa MM, Ramilo O, et al. Tumor necrosis factor α and interleukin 1β in synovial fluid of infants and children with suppurative arthritis. Am J Dis Child 1990; 144: 353-6
17. Saez-Llorens X, Jafari HS, Olsen KD, et al. Induction of suppurative arthritis in rabbits by Haemophilus endotoxin, tumor necrosis factor-alpha, and interleukin-1 beta. J Infect Dis 1991; 163: 1267-72
18. Cunningham R, Cockayne A, Humphreys H. Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol 1996; 44: 157-64
19. Bremell T, Tarkowski A. Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect Immun 1995; 63: 4185-7
20. Zhao YX, Ahdelnour A, Holmdahl R, et al. Mice with the xid B cell defect are less susceptible to developing staphylococcus aureus-induced arthritis. J Immunol 1995; 155: 2067-76
21. Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med 1985; 312: 764-71
22. Petersen BH, Lee TJ, Snyderman R, et al. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7 or C8 deficiency. Ann Intern Med 1979; 90: 917-20
23. Goldenberg DL. Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum 1989; 32: 496-502
24. Went P, Krismer M, Frischhut B. Recurrence of infection after revision of infected hip arthroplasties. J Bone Joint Surg Br 1995; 77: 307-9
25. Gray RG, Gottlieb NL. Intra-articular corticosteroids: an updated assessment. Clin Orthop Rel Res 1983; 177: 235-63
26. Östennson A, Geborek P. Septic arthritis as non-surgical complication in rheumatoid arthritis: relation to disease activity and therapy. Br J Rheumatol 1991; 30: 35-8
27. Armstrong RW, Bolding F. Septic arthritis after arthroscopy: the contributing roles of intraarticular steroids and environmental factors. Am J Infect Control 1994; 22: 16-8
28. Dubost JJ, Fis I, Denis P, et al. Polyarticular septic arthritis. Medicine 1993; 72: 296-310
29. Pfister HW, Wilske B, Weber K. Lyme borreliosis: basic science and clinical aspects. Lancet 1994; 343: 1013-6
30. Stanek G, O'Connell S, Cimmino MA, et al. European Union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741-7
31. Haupl T, Hahn G, Rittig M, et al. Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum 1993; 36: 1621-6
32. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Int Med 1987; 107: 725-31
33. Shmerling RH, Delbanco TL, Tosteson ANA, et al. Synovial fluid tests: what should be ordered? JAMA 1991; 264: 1009-14
34. Singleton JD, West SG, Nordstrom DM. Pseudoseptic arthritis complicating rheumatoid arthritis: a report of six cases. J Rheumatol 1991; 18: 1319-22
35. McCarty DJ. Synovial fluid. In: McCarty DJ, editor. Arthritis and allied conditions. Philadelphia: Lea and Febiger, 1979; 51-69
36. Kortekangas P, Aro HT. Synovial fluid leukocytosis in bacterial arthritis vs reactive arthritis and rheumatoid arthritis in the adult knee. Scand J Rheumatol 1992; 21: 283-8
37. Gratacos J, Vila J, Moya F, et al. D-lactic acid in synovial fluid: a rapid diagnostic test for bacterial arthritis. J Rheumatol 1995; 22: 1504-8
38. Cimmino MA, Tobia F, Pesce CM, et al. Alkaline phosphatase activity of the synovial fluid and membrane. In: Hämäläinen M, Hagena FW, Schwägerl W, et al., editors. Revisional surgery in rheumatoid arthritis. Basel: Karger, 1990; 172-85
39. Borenstein DG, Gibbs CA, Jacobs RP. Gas-liquid chromatographic analysis of synovial fluid. Arthritis Rheum 1982; 25: 947-53
40. Dory MA, Wautelet MJ. Arthroscopy in septic arthritis. Arthritis Rheum 1985; 28: 198-203
41. Liebling MR, Arkfeld DG, Michelini GA, et al. Identification of Neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction. Arthritis Rheum 1994; 37: 702-9
42. Lim-Dunham JE, Ben-Ami TE, Yousefzadeh DK, et al. Septic arthritis of the elbow in children: the role of sonography. Pediatr Radiol 1995; 25: 556-9
43. Sandrasegaran K, Saifuddin A, Coral A, et al. Magnetic resonance imaging of septic sacroiliitis, Skeletal Radiol 1994; 23: 289-92
44. Sundberg SB, Savage JP, Foster BK, Technetium phosphate bone scan in the diagnosis of septic arthritis in childhood. J Pediatr Orthop 1989; 9: 579-83
45. Flivik G, Sloth M, Rydholm U, et al. Technetium-99m-nanocolloid scintigraphy in orthopedic infections: a comparison with indium-111-labeled leukocytes. J Nucl Med 1993; 34: 1646-50
46. Ooi GC, Belton I, Finlay D. Comparison of technetium 99m nanocolloid and indium 111 leucocytes in the diagnosis of orthopedic infections. Br J Radiol 1993; 66: 1025-30
47. Mudun A, Unal S, Aktay R, et al. Tc-99m nanocolloid and Tc-99m MDP three-phase bone imaging in osteomyelitis and septic arthritis: a comparative study. Clin Nucl Med 1995; 20: 772-8
48. Barrow SA, Graham W, Jyawook S, et al. Localization of indium-111-immunoglobulin G, technetium 99m immunoglobulin G and indium-111-labeled while blood cells at sites of acute bacterial infection in rabbits. J Nucl Med 1993; 34: 1975-9
49. Thomas PA, Mullan B. Avidin indium 111-labeled WBC accumulation in a patient with active ostcoarthritis of both knees. Clin Nucl Med 1995; 20: 973-5
50. Ho Jr G. How best to drain an infected joint: will we ever know for certain? Rheumatol 1993; 20: 2001-3
51. Jackson RW, The minimally invasive treatment of septic arthritis [editorial]. J Rheumatol 1993; 20: 2004
52. Ike RW. Tidal irrigation in septic arthritis of the knee: a potential alternative to surgical drainage. J Rheumatol 1993; 21: 2104-11
53. Chung WK, Slater GL, Bates EH. Treatment of septic arthritis of the hip by arthroscopic lavage. J Pediatr Orthop 1993; 13: 444-6
54. Nord KD, Dore DD, Deeney VF, et al. Evaluation of treatment modalities for septic arthritis with histological grading and analysis of levels of uronic acid, neutral protease, and interleukin-1. J Bone Joint Surg Am 1995; 77: 258-65
55. Fung MF, Louie JS. Infectious agent arthritis. In: Weisman MH, Weinblatt ME. editors. Treatment of the rheumatic diseases. Philadelphia: Saunders, 1995: 321-4
56. Tissi L, von Hunolstein C, Mosci P, et al. In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B streptococcus strain in mice: comparative study with erythromycin and penicillin G. Antimicrob Agents Chemother 1995; 39: 1938-47
57. Schurman DJ, Kajiyama G. Antibiotic absorption from infected and normal joints using a rabbit knee model. J Orthop Res 1985; 3: 185-4
58. Orchard RA, Stamp WG. Early treatment of induced suppurative arthritis in rabbit knee joints. Clin Orthop 1968; 59: 287-91
59. Jafari HS, Saez-Llorens X, Paris M, et al. Dexamethasone attenuation of cytokine-mediated articular cartilage degradation in experimental lapine haemophilus arthritis. J Infect Dis 1993; 168: 1186-93
60. Wysenbeek AJ, Leitman M, Amit M, et al. Experimental septic arthritis in rabbits treated by a combination of antibiotic and steroid drugs. Clin Exp Rheumatol 1996; 14: 507-12
61. Ricci ML, von Hunolstein C, Gomez MJ, et al. Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus. J Med Microbiol 1996; 44: 475-81
62. Cimmino MA, Moggiana GL, Parisi M, et al. Treatment of Lyme arthritis. Infection 1996; 24: 91-4
63. Cimmino MA, Accardo S. Long term treatment of chronic Lyme arthritis with benzathine penicillin. Ann Rheum Dis 1992; 51: 1007-8
64. Schoen RT, Aversa JM, Rahn DW, et al. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy. Arthritis Rheum 1991; 34: 1056-60
65. Cole AA, Chubinskaya S, Luchene LJ, et al. Doxycycline disrupts chondrocyte differentiation and inhibits cartilage matrix degradation. Arthritis Rheum 1994; 37: 1727-34
66. Lidwell OM, Elson RA, Lowbury EJ, et al. Ultraclean air and antibiotics for the prevention of postoperative infection: a multicenter study of 8052 joint replacement operations. Acta Orthop Scand 1987; 58: 4-12
67. Peters RHJ, Rasker JJ, Jacobs JWG, et al. Bacterial arthritis in a district hospital. Clin Rheumatol 1992; 152: 351-5
68. Esterhai Jr JL, Gelb I. Adult septic arthritis. Orthop Clin North Am 1991; 22: 503-14